Ocumetra

20/02/2026

New Article Alert 🚨
We are thrilled to share a new article featuring the brilliant Dr. Brianna Rhue!

This article details Dr Rhue’s experience tackling Myopia Management with the use of mEYE® Suite.

A big thank you to our friends at Review of Myopia Management for helping bring this together!

You can read the full article here: https://reviewofmm.com/how-meye-suite-transformed-my-myopia-management-practice/

13/02/2026

Heading to 100% Optical?
Transform your myopia management offering with mEYE® Suite.

- Simplify complex conversations and build confidence in every recommendation.
- Share each child’s myopia report instantly with parents via QR code
- Vision Simulator & in-chair visualisation tools create powerful “aha” moments that drive treatment uptake & retention
- mEYE® Score shows progress over time, reassuring families, strengthening trust, and supporting long-term eye health

Clinical Clarity. Commercial Growth. That’s what mEYE® Suite delivers.

Book your personal demo session at 100% Optical and see how mEYE® Suite can elevate your approach to myopia management.

https://ocumetra2.pipedrive.com/scheduler/expOvaFP/meye-suite-demo-100-optical-2026

06/02/2026

Our good friends at Myopia Profile sat down with our Co-Founder and CEO, Professor James Loughman, to speak about the science underpinning Ocumetra’s mEYE® Suite platform of clinical and communication tools, the role of centile-based visuals and axial length interpretation, and how clinical decision-support tools can help bridge the gap between evidence, practice, and parent understanding.

Read it here: https://www.myopiaprofile.com/articles/improving-myopia-conversations-QandA-James-Loughman

29/01/2026

Say hello to Kate, our Director of Operations!

We sat down with Kate to learn more about her impressive background and hear what excites her most about the future of the eyecare industry.
——
How would you describe your role at Ocumetra?

As Director of Operations at Ocumetra, I’m essentially the air-traffic controller: making sure all the planes - product, HR, regulatory, customer support, and operations - take off, land, and don’t collide. My job is to keep the company flying smoothly while we head towards new horizons.

What is your clinical background?

I’m a medical doctor with a PhD focused on nutritional therapies for glaucoma. Rather than going into clinical practice, I moved into research and was then happily absorbed by the medtech industry, which I’ve found endlessly fascinating ever since.

What first drew you to the industry?

I’ve always had a genuine passion for vision and the huge role it plays in our lives - from learning and exploration to creativity and art. Because vision has such a profound impact on quality of life, working to prevent avoidable vision loss felt like a very natural and meaningful path for me.

What keeps you motivated in the industry day-to-day?

I’m motivated by seeing tangible impact. For us, that often comes from speaking with eyecare professionals and hearing how our products make their work easier or more effective. I’m also constantly energised by the pace of innovation in healthcare and the sense that we’re always on the edge of what’s coming next.

What excites you most about where the industry is heading?

The potential of AI is incredibly exciting - from AI-powered diagnostics to smarter clinical workflows and more personalised patient care.

21/01/2026

In eyecare, confidence in your technology matters.

mEYE® Suite is trusted by ECPs across the globe, and here's why:

- ISO 27001 Certified: Ocumetra is ISO/IEC 27001 certified for information security and operates a quality management system, ensuring the highest standards of data protection and product quality.

- Global Database 1m+: mEYE® Suite is built on a foundation of biometric and demographic data of over 1 million patient records.

- Data Security: We adhere to data protection regulations (GDPR and HIPAA), ensuring patient information is handled securely.

14/01/2026

We’re Hiring!

We’re seeking a passionate and knowledgeable Professional Affairs Consultant to represent Ocumetra across UK, Ireland and the rest of Europe.

In this role, you’ll serve as one of the clinical and professional voices of Ocumetra, building trusted relationships with eyecare practitioners, industry partners, and key opinion leaders.

Every day, our mission is simple: help clinicians deliver better outcomes for millions of children worldwide. If that inspires you, we’d love to meet you.

Take a look at the full job spec here: https://ocumetra.hirehive.com/professional-affairs-consultant-remote-dublin-k7W8yC

07/01/2026

Hello 2026! 👋 Our priorities at Ocumetra remain clear and consistent.

Key areas of focus include:
- Empowering ECPs to deliver outstanding personalised myopia care
- Improving eye health for children globally
- Building and strengthening the Ocuverse with talented new team members
- Driving engineering excellence in our software to ensure robust, secure, and scalable clinical solutions

Here’s to a year of continued progress and meaningful impact.

22/12/2025

Seasons Greetings from our team to yours! 🎄

Time to switch off those Slack and LinkedIn notifications for a few days (or hours at least!) 🔕

As the year wraps up, we’re grateful for the conversations, collaborations, and shared curiosity across the eye care community.

Thanks for making 2025 such a good one. 🙌

16/12/2025

We suspected something was brewing… and here it is. 👀

Ian Flitcroft, together with a powerhouse team: Gareth Lingham; Gui-Shuang Ying; Hongguang Cui; David A. Mackey; Jost B. Jonas;
Mukharram M. Bikbov; Siofra Harrington; Kathryn J. Saunders; and James Loughman, have just published another standout paper. 💡

Introducing:
“Refractive Error Centile Curves for Asian and Western Children and Adolescents: An Individual Level Meta-Analysis.”

Another important step forward for evidence-based myopia care, and a testament to what collaborative science can achieve.

📘 Read the full article:
https://iovs.arvojournals.org/article.aspx?articleid=2811200

09/12/2025

✨ A big thank you to last night’s clinical lecture panelist, Sarah Douglas! ✨

It was fantastic to see so many clinicians join us as Corrina McElduff and Sarah Douglas unpacked the real-world challenges of myopia management — from building trust with parents to driving better treatment compliance in everyday practice.

🙏 Special thanks to our friends at Ocuco for sponsoring the event and making it possible.

If you missed out and want to stay in the loop for the next clinical lecture, make sure to follow our page! 👀

02/12/2025

🚨 Upcoming Clinical Lecture: The Realities of Myopia Management
📅 Monday, December 8th
🕗 6:30pm

Join our Director of Professional Affairs, Corrina McElduff, and a panel of experts as they examine key challenges in myopia management and offer evidence-based strategies to build trust, communicate effectively with parents, and improve treatment compliance.

🎓 This Clinical Lecture is worth 1 interactive CPD point (UK, IE, NO, SE, DK)

🎟 Places are limited — reserve your spot now: https://us02web.zoom.us/webinar/register/WN_lG-lfrthThGWVfQskV607A?utm_content=480776405&utm_medium=social&utm_source=linkedin&hss_channel=lcp-130150 #/registration

A big shout out to our friends at Ocuco who are sponsoring the event.

02/10/2025

A new summary report from the Global Myopia Public Health Summit highlights urgent gaps and opportunities in combating the worldwide rise of myopia.

📈 Myopia rates continue to climb, yet many regions lack reliable data and access to cost-effective interventions.
🌍 Large-scale government initiatives — including school vision screening, outdoor activity promotion, and public awareness campaigns — show promise for slowing progression.
💡 The report calls for stronger practitioner education, improved data collection, and evaluation of intervention cost-effectiveness to guide sustainable strategies.

Read the paper:

The World Health Organization (WHO) recognizes myopia as a significant public health concern, as its prevalence has been rising at an alarming rate worldwide. In the WHO's Global Action Plan for the Prevention of Avoidable Blindness and Visual Impairment 2014-2019, myopia has already been identified...